Influence of drug transporter expression on the pharmacokinetics of the HIV protease inhibitor Kaletra (lopinavir/ritonavir) and on the concentration relations between plasma, blood cells, saliva and urine
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2009
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 12 Feb 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 12-2-2009.
- 12 Feb 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2005 New trial record.